Background pattern
CLOPIDOGREL KRKA 75 mg FILM-COATED TABLETS

CLOPIDOGREL KRKA 75 mg FILM-COATED TABLETS

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use CLOPIDOGREL KRKA 75 mg FILM-COATED TABLETS

Introduction

Package Leaflet: Information for the User

Clopidogrel Krka 75 mg Film-Coated Tablets EFG

clopidogrel

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack and other information:

  1. What is Clopidogrel Krka and what is it used for
  2. What you need to know before you take Clopidogrel Krka
  1. How to take Clopidogrel Krka
  1. Possible side effects
  2. Storing Clopidogrel Krka
  1. Contents of the pack and other information

1. What is Clopidogrel Krka and what is it used for

Clopidogrel Krka contains clopidogrel and belongs to a group of medicines called antiplatelet agents. Platelets are very small cells in the blood that clump together to form blood clots. Antiplatelet agents prevent this clumping, reducing the risk of blood clots (a process called thrombosis).

Clopidogrel Krka is given to adults to prevent blood clots (thrombi) in blood vessels (arteries) that have become hardened, a process known as atherothrombosis, which can lead to atherothrombotic events (such as stroke, myocardial infarction, or death).

You have been prescribed Clopidogrel Krka to help prevent blood clots and reduce the risk of these serious events because:

  • you have a condition that causes hardening of the arteries (also known as atherosclerosis), and
  • you have previously had a myocardial infarction, a stroke, or suffer from a disease called peripheral arterial disease, or
  • you have had a type of severe chest pain known as "unstable angina" or "myocardial infarction". For the treatment of this disease, your doctor may need to place a stent in the obstructed or narrowed artery to restore proper blood flow. Your doctor may also have prescribed acetylsalicylic acid (a substance found in many medications used to relieve pain and reduce fever, as well as to prevent blood clots).
  • you have an irregular heartbeat, a disease called "atrial fibrillation", and you cannot take medications known as "oral anticoagulants" (vitamin K antagonists) that prevent the formation of new clots and prevent the growth of existing clots. You will have been told that "oral anticoagulants" are more effective than acetylsalicylic acid or the combined use of Clopidogrel Krka and acetylsalicylic acid for this disease. Your doctor will have prescribed Clopidogrel Krka plus acetylsalicylic acid if you cannot take "oral anticoagulants" and do not have a risk of severe bleeding.

2. What you need to know before you take Clopidogrel Krka

Do not take Clopidogrel Krka

  • If you are allergic to clopidogrel or any of the other ingredients of this medicine (listed in section 6);
  • If you have an active bleeding, such as a stomach ulcer or bleeding in the brain;
  • If you have a severe liver disease.

If you think any of these apply to you, or if you are in any doubt, consult your doctor before taking Clopidogrel Krka.

Warnings and precautions

Before starting treatment with Clopidogrel Krka, inform your doctor if you are in any of the following situations:

  • If you are at risk of bleeding because:
  • you have a disease that involves a risk of internal bleeding (such as a stomach ulcer).
  • you have a blood disorder that predisposes you to internal bleeding (bleeding in tissues, organs, or joints of the body).
  • you have recently had a severe injury.
  • you have recently undergone surgery (including dental surgery).
  • you are scheduled to undergo surgery (including dental surgery) in the next seven days.
  • If you have had a blood clot in an artery of the brain (ischemic stroke) in the last 7 days.
  • If you have liver or kidney disease.
  • If you have had an allergy or reaction to any medication used to treat your disease.

During treatment with Clopidogrel Krka:

  • Tell your doctor if you are scheduled to have surgery (including dental surgery).
  • Tell your doctor immediately if you develop a disorder (also known as Thrombotic Thrombocytopenic Purpura or TTP) that includes fever and bruising (bleeding under the skin that can appear as red spots), accompanied or not by unexplained extreme tiredness, confusion, yellowing of the skin or eyes (jaundice) (see section 4 "Possible side effects").
  • If you cut or injure yourself, bleeding may take longer than usual to stop. This is related to the way the medicine works, as it prevents the blood from forming clots. For minor cuts or injuries, such as cuts while shaving, this is usually not a problem. However, if you are concerned about your bleeding, consult your doctor immediately (see section 2 "Warnings and precautions").
  • Your doctor may ask you to have blood tests.

Children and adolescents

This medicine should not be given to children because it is not effective.

Other medicines and Clopidogrel Krka

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.

Some medicines may affect the use of Clopidogrel Krka or vice versa.

You must specifically tell your doctor if you are taking:

  • medicines that may increase the risk of bleeding, such as:
    • oral anticoagulants, medications used to decrease blood clotting,
  • non-steroidal anti-inflammatory drugs, medications used to treat pain and/or inflammation of muscles or joints,
  • heparin, or any other injectable medication used to decrease blood clotting,
  • ticlopidine, another antiplatelet agent,
    • a serotonin reuptake inhibitor (such as fluoxetine or fluvoxamine and other medications of the same type), medications used to treat depression,
  • omeprazole or esomeprazole, medications to treat stomach discomfort,
  • fluconazole or voriconazole, medications to treat fungal infections,
  • efavirenz, a medication to treat HIV (human immunodeficiency virus) infections,
  • carbamazepine, a medication to treat some forms of epilepsy,
  • moclobemide, a medication for depression,
  • repaglinide, a medication for the treatment of diabetes,
  • paclitaxel, a medication for the treatment of cancer,
  • antiretrovirals (medications to treat HIV infection).

If you have had severe chest pain (unstable angina or myocardial infarction), you may have been prescribed Clopidogrel Krka in combination with acetylsalicylic acid, a substance found in many medications used to relieve pain and reduce fever. A dose of acetylsalicylic acid taken occasionally (not exceeding 1,000 mg in 24 hours) is generally not a problem, but prolonged use in other circumstances should be discussed with your doctor.

Taking Clopidogrel Krka with food and drinks

Clopidogrel Krka can be taken with or without food.

Pregnancy and breastfeeding

It is preferable not to take this medicine during pregnancy.

If you are pregnant or think you may be pregnant, you must inform your doctor or pharmacist before taking Clopidogrel Krka. If you become pregnant while taking Clopidogrel Krka, consult your doctor immediately, as it is not recommended to take clopidogrel during pregnancy.

You should not breastfeed while taking this medicine.

If you are breastfeeding or plan to breastfeed, inform your doctor before taking this medicine.

Consult your doctor or pharmacist before using any medication.

Driving and using machines

Clopidogrel Krka is unlikely to affect your ability to drive or use machines.

3. How to take Clopidogrel Krka

Follow exactly the instructions of administration of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

The recommended dose, even for patients with a disease called "atrial fibrillation" (an irregular heartbeat), is one 75 mg tablet of Clopidogrel Krka per day, taken orally, with or without food, and at the same time each day.

If you have had severe chest pain (unstable angina or myocardial infarction), your doctor may prescribe 300 mg of Clopidogrel Krka (4 tablets of 75 mg) to be taken once at the start of treatment. After that, the recommended dose is one 75 mg tablet of Clopidogrel Krka per day, as described above.

You should take Clopidogrel Krka for as long as your doctor continues to prescribe it.

If you take more Clopidogrel Krka than you should

Contact your doctor or go to the nearest hospital emergency department, as there is a higher risk of bleeding.

If you forget to take Clopidogrel Krka

If you forget to take a dose of Clopidogrel Krka, but remember before 12 hours have passed since the time you should have taken the medication, take the tablet immediately and the next one at the usual time.

If you forget for more than 12 hours, simply take the next dose at the usual time. Do not take a double dose to make up for a forgotten tablet.

If you stop taking Clopidogrel Krka

Do not stop your treatment unless your doctor tells you to.Consult your doctor or pharmacist before stopping this medicine.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Consult your doctor immediately if you experience:

  • Fever, signs of infection, or extreme tiredness. These symptoms may be due to a rare decrease in some blood cells.
  • Signs of liver problems, such as yellowing of the skin and/or eyes (jaundice), associated or not with bleeding that appears under the skin as red spots and/or confusion (see section 2 "Warnings and precautions").
  • Swelling of the mouth or skin disorders such as rashes and itching, blisters on the skin. These can be signs of an allergic reaction.

The most common side effect reported with Clopidogrel Krka is bleeding.

Bleeding may occur in the stomach or intestine, bruising, hematoma (abnormal bleeding or bruising under the skin), nosebleeds, blood in urine. A small number of cases of bleeding in the blood vessels of the eyes, intracranial, pulmonary, or joint bleeding have also been reported.

If you experience prolonged bleeding while taking Clopidogrel Krka

If you cut or injure yourself, it is possible that bleeding may take a little longer than usual to stop. This is related to the mechanism of action of the medicine, as it prevents the blood from forming clots. For minor cuts or injuries, such as cuts while shaving, this is usually not a problem. However, if you are concerned about your bleeding, consult your doctor immediately (see section 2 "Warnings and precautions").

Other side effects include:

Common side effects (may affect up to 1 in 10 people):

Diarrhea, abdominal pain, indigestion, or heartburn.

Uncommon side effects (may affect up to 1 in 100 people):

Headache, stomach ulcer, vomiting, nausea, constipation, excess gas in the stomach or intestine, rash, itching, dizziness, tingling, and numbness.

Rare side effects (may affect up to 1 in 1,000 people):

Dizziness, breast enlargement in men.

Very rare side effects (may affect up to 1 in 10,000 people):

Jaundice; severe abdominal pain with or without back pain; fever, difficulty breathing, sometimes associated with cough; generalized allergic reactions (e.g., general feeling of heat with sudden general discomfort leading to fainting); swelling of the mouth; blisters on the skin; skin allergy; inflammation of the mucous membrane of the mouth (stomatitis); low blood pressure; confusion; hallucinations; joint pain; muscle pain; changes in taste or loss of taste of food.

Side effects with unknown frequency (cannot be estimated from available data): Hypersensitivity reactions with chest or abdominal pain, persistent symptoms of low blood sugar levels.

Your doctor may also observe changes in the results of your blood or urine tests.

Reporting of side effects

If you experience any side effects, consult your doctor or pharmacist, even if it is possible that they are not listed in this leaflet. You can also report side effects directly through the national reporting system included in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storing Clopidogrel Krka

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date is the last day of the month shown.

Store in the original package to protect from light and moisture.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Package Contents and Additional Information

Clopidogrel Krka Composition

  • The active ingredient is clopidogrel. Each film-coated tablet contains 75 mg of clopidogrel (as hydrochloride).
  • The other ingredients are: microcrystalline cellulose, anhydrous colloidal silica, crospovidone (type A), macrogol 6000, and hydrogenated castor oil in the tablet, and polyvinyl alcohol, titanium dioxide (E171), red iron oxide (E172), yellow iron oxide (E172), talc, and macrogol 3000 in the film coating.

Appearance of Clopidogrel Krka and Package Contents

Film-coated tablets are pink, round, and slightly convex.

Boxes of 7, 14, 28, 30, 50, 56, 60, 84, 90, 100, 112, and 120 film-coated tablets in blisters.

Marketing Authorization Holder

KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia

Manufacturers

KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia TAD Pharma GmbH, Heinz-Lohmann-Strasse 5, 27472 Cuxhaven, Germany

You can request more information about this medicinal product by contacting the local representative of the marketing authorization holder:

Belgium

KRKA Belgium, SA.

Tel: +32 (0) 487 50 73 62

Lithuania

UAB KRKA Lietuva

Tel: +370 5 236 27 40

Bulgaria

KRKA Bulgaria EOOD

Tel: +359 (02) 962 34 50

Luxembourg

KRKA Belgium, SA.

Tel: +32 (0) 487 50 73 62 (BE)

Czech Republic

KRKA CR, s.r.o.

Tel: +420 (0) 221 115 150

Hungary

KRKA Magyarország Kereskedelmi Kft.

Tel: +36 (1) 355 8490

Denmark

KRKA Sverige AB

Tel: +46 (0)8 643 67 66 (SE)

Malta

  • J. Busuttil Ltd.

Tel: +356 21 445 885

Germany

TAD Pharma GmbH

Tel: +49 (0) 4721 606-0

Netherlands

KRKA Belgium, SA.

Tel: +32 (0) 487 50 73 62 (BE)

Estonia

KRKA, d.d., Novo mesto Eesti filiaal

Tel: +372 (0)6 671 658

Norway

KRKA Sverige AB

Tel: +46 (0)8 643 67 66 (SE)

Greece

QUALIA PHARMA S.A.

Tel: +30 210 6256177

Austria

KRKA Pharma GmbH, Wien

Tel: +43 (0)1 66 24 300

Spain

KRKA Farmacéutica S.L.

Tel: +34 911 61 03 81

Poland

KRKA-POLSKA Sp. z o.o.

Tel: +48 (0)22 573 7500

France

KRKA France Eurl

Tel: +33 (0)1 57 40 82 25

Portugal

KRKA Farmacêutica, Sociedade Unipessoal Lda.

Tel: +351 (0)21 46 43 650

Croatia

KRKA – FARMA d.o.o.

Tel: +385 1 6312 100

Romania

KRKA Romania S.R.L., Bucharest

Tel: +4 021 310 66 05

Ireland

KRKA Pharma Dublin, Ltd.

Tel: +353 1 293 91 80

Slovenia

KRKA, d.d., Novo mesto

Tel: +386 (0) 1 47 51 100

Iceland

LYFIS ehf.

Tel: +354 534 3500

Slovakia

KRKA Slovensko, s.r.o.

Tel: +421 (0) 2 571 04 501

Italy

KRKA Farmaceutici Milano S.r.l.

Tel: +39 02 3300 8841

Finland

KRKA Finland Oy

Tel: +358 20 754 5330

Cyprus

Kipa Pharmacal Ltd.

Tel: +357 24 651 882

Sweden

KRKA Sverige AB

Tel: +46 (0)8 643 67 66 (SE)

Latvia

KRKA Latvija SIA

Tel: +371 6 733 86 10

United Kingdom

KRKA UK Ltd.

Tel: +44 (0) 207 400 3352

Date of Last Revision of this Leaflet:

Detailed information on this medicinal product is available on the European Medicines Agency website http://www.ema.europa.eu/.

About the medicine

How much does CLOPIDOGREL KRKA 75 mg FILM-COATED TABLETS cost in Spain ( 2025)?

The average price of CLOPIDOGREL KRKA 75 mg FILM-COATED TABLETS in October, 2025 is around 16.81 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.

Get updates and exclusive offers

Be the first to know about new services, marketplace updates, and subscriber-only promos.

Follow us on social media
FacebookInstagram
Logo
Oladoctor
Find a doctor
Doctors by specialty
Services
Choose language
© 2025 Oladoctor. All rights reserved.
VisaMastercardStripe